Tachi Yamada
Tachi Yamada was born in Tokyo, Japan on June 5th, 1945 and is the American Doctor. At the age of 78, Tachi Yamada biography, profession, age, height, weight, eye color, hair color, build, measurements, education, career, dating/affair, family, news updates, and networth are available.
At 78 years old, Tachi Yamada physical status not available right now. We will update Tachi Yamada's height, weight, eye color, hair color, build, and measurements.
Prior to Frazier Healthcare Partners, Yamada was Executive Vice-President and a Board Member of Takeda Pharmaceuticals, and served as the Chief Medical and Scientific Officer of the company.
Before joining Takeda, Yamada was the President of the Global Health Program at the Bill & Melinda Gates Foundation. In this capacity he oversaw grants totaling over $9 billion in programs directed at applying technologies to address major health challenges of the developing world including TB, HIV, malaria and other infectious diseases, malnutrition and maternal and child health. Yamada served as Chairman of Research and Development and was a member of the Board of Directors at GlaxoSmithKline before joining the foundation.
In recognition of his contributions to medicine and science he was elected to membership in the National Academy of Medicine (US) and the National Academy of Medicine (Mexico) and to Fellowship in the Academy of Medical Sciences (UK) and the American Academy of Arts and Sciences.
Among his many other activities he was a member of the Board of Directors of public corporations across four continents and was a member of the Board of Agilent Technologies and chaired the Boards of Phathom Pharmaceuticals and Passage Bio, two companies for which he was a founder. He also served as a member of the President’s Council of Advisors on Science and Technology, Vice-Chair of the Council of the National Academy of Medicine (US), President of the Association of American Physicians and President of the American Gastroenterological Association. He served as a member of the Board of the University of Michigan Health System and as Chairman of the Board of the Clinton Health Access Initiative.